Trials / Not Yet Recruiting
Not Yet RecruitingNCT06768411
The Dosage Exploration Study of PEG-rhGH for Treating Short Stature in Prepubertal and Pubertal Children
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 240 (estimated)
- Sponsor
- Second Affiliated Hospital of Wenzhou Medical University · Academic / Other
- Sex
- All
- Age
- 1 Year – 16 Years
- Healthy volunteers
- Not accepted
Summary
This study is dedicated to addressing the lack of research on the most effective dosage of long-acting growth hormone for children with short stature. By employing clinical trial design, we are committed to investigating the therapeutic benefits and safety profiles associated with varying doses of long-acting growth hormone. Our ultimate goal is to offer clinicians more precise treatment guidance and assist patients in attaining optimal growth and developmental outcomes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PEG-rhGH | 1= 0.2mg/kg/week Initial doses of PEG-rhGH 2=0.22mg/kg/week Initial doses of PEG-rhGH |
| DRUG | GnRHa | 1. pubertal children of short stature without GnRHa treatment 2. pubertal children of short stature with GnRHa treatment |
Timeline
- Start date
- 2025-01-15
- Primary completion
- 2026-12-30
- Completion
- 2027-06-01
- First posted
- 2025-01-10
- Last updated
- 2025-01-10
Source: ClinicalTrials.gov record NCT06768411. Inclusion in this directory is not an endorsement.